Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders

Lothar Gremer1, Torsten Merbitz-Zahradnik, Radovan Dvorsky

  • 1Institute of Biochemistry and Molecular Biology II, Heinrich-Heine University, Düsseldorf, Germany.

Human Mutation
|October 16, 2010
PubMed

Insights

Germline KRAS mutations cause developmental disorders like Noonan syndrome. This study classifies ten KRAS mutations by their biochemical and structural changes, explaining disease variability.

Area of Science:

  • Molecular biology
  • Genetics
  • Biochemistry

Background:

  • The KRAS gene is frequently mutated in cancer.
  • Germline KRAS mutations are linked to developmental disorders such as Noonan syndrome (NS), cardio-facio-cutaneous syndrome (CFCS), and Costello syndrome (CS).
  • The molecular mechanisms driving the diverse phenotypes in these syndromes remain incompletely understood.

Purpose of the Study:

  • To comprehensively analyze the biochemical and structural characteristics of ten distinct germline KRAS mutations.
  • To elucidate the molecular basis for the phenotypic variability observed in patients with germline KRAS mutations.

Main Methods:

  • Utilized physical and cellular biochemistry techniques.
  • Performed comprehensive analysis of ten germline KRAS mutations.
  • Grouped mutants based on distinct biochemical and structural alterations.

Main Results:

  • Identified five distinct classes of germline KRAS mutants based on biochemical and structural properties.
  • Four of these classes exhibited significant differences compared to RAS oncoproteins.
  • Observed functional alterations including enhanced nucleotide exchange (intrinsic and GEF-catalyzed), impaired GTP hydrolysis (GAP-stimulated), loss of function, and deficient effector interaction.

Conclusions:

  • Germline KRAS mutations play a significant role in the pathogenesis of NS, CFCS, and CS.
  • The diverse biochemical and structural alterations of KRAS mutants provide insights into the phenotypic variability in related developmental disorders.
  • This research deepens the understanding of RAS pathway dysregulation in human development.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Mutations01:39

Mutations

Overview
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: